- Home
- VCEL vs SLVM Comparison
VCEL vs SLVM Comparison
Compare VCEL & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | SLVM |
|---|---|---|
| Founded | 1989 | 1898 |
| Country | United States | United States |
| Employees | N/A | 6500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VCEL | SLVM |
|---|---|---|
| Price | $33.74 | $42.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $58.50 | $54.00 |
| AVG Volume (30 Days) | ★ 718.0K | 318.4K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | ★ 60.00 | N/A |
| EPS | 0.32 | ★ 3.24 |
| Revenue | $276,259,000.00 | ★ $3,351,000,000.00 |
| Revenue This Year | $19.10 | $0.98 |
| Revenue Next Year | $17.95 | $2.28 |
| P/E Ratio | $106.66 | ★ $13.20 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $37.09 |
| 52 Week High | $45.97 | $62.99 |
Technical Indicators
Market Signals| Indicator | VCEL | SLVM |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 50.24 |
| Support Level | $30.41 | $41.56 |
| Resistance Level | $34.34 | $43.81 |
| Average True Range (ATR) | 1.76 | 1.36 |
| MACD | 0.29 | 0.60 |
| Stochastic Oscillator | 83.11 | 96.08 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.